1. Combination with third‐generation bisphosphonate (YM529) and interferon‐alpha can inhibit the progression of established bone renal cell carcinoma. Issue 8 (14th July 2015) Authors: Kurabayashi, Atsushi; Inoue, Keiji; Fukuhara, Hideo; Karashima, Takashi; Fukata, Satoshi; Kawada, Chiaki; Shuin, Taro; Furihata, Mutsuo Journal: Cancer science Issue: Volume 106:Issue 8(2015:Aug.) Page Start: 1092 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current status of photodynamic technology for urothelial cancer. Issue 2 (2nd December 2021) Authors: Inoue, Keiji; Fukuhara, Hideo; Yamamoto, Shinkuro; Karashima, Takashi; Kurabayashi, Atsushi; Furihata, Mutsuo; Hanazaki, Kazuhiro; Lai, Hung Wei; Ogura, Shun‐Ichiro Journal: Cancer science Issue: Volume 113:Issue 2(2022) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Urinary laminin‐γ2 is a novel biomarker of non‐muscle invasive urothelial carcinoma. Issue 12 (6th November 2015) Authors: Kamada, Masayuki; Koshikawa, Naohiko; Minegishi, Tomoko; Kawada, Chiaki; Karashima, Takashi; Shuin, Taro; Seiki, Motoharu Journal: Cancer science Issue: Volume 106:Issue 12(2015:Dec.) Page Start: 1730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗